Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs
The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.
The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.
Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of mycobacteria with “kill switches” that can be triggered
WASHINGTON — Sen. Chuck Schumer (D-N.Y.), the most powerful person in the U.S. Senate, wants the Food and Drug Administration to investigate the increasingly popular